571 Results (Page 23 of 23)
UK Markets Research Reports
UK Actinic Keratosis Therapeutic Market Analysis
The UK Actinic Keratosis Therapeutic Market is predicted to develop at a CAGR of 2.9%, increasing from $177 Mn in the year 2022 to $222 Mn by the year 2030. The UK Actinic Keratosis Therapeutic Market is expected to grow at a faster rate during the forecast period, owing to a large patient population, increased awareness about the prevention and treatment of Actinic Keratosis, and advancements in medical technology leading to the development of innovative and minimally invasive procedures. Some domestic firms, such as GlaxoSmithKline and Scancell, as well as international Sun Pharmaceuticals, Biofrontera, Nestle, Bausch Health, etc are key competitors in the industry
UK Constipation Therapeutics Market Analysis
UK Constipation Therapeutics Market was valued at $473 Mn in 2022 and is estimated to reach $673 Mn in 2030, exhibiting a CAGR of 4.5% during the forecast period. The constipation therapeutics market is experiencing growth driven by the rising prevalence of constipation worldwide, attributed to factors like aging, sedentary lifestyles, and unhealthy dietary habits, with the expanding elderly population, more prone to chronic conditions, further contributing to this market expansion. Notable participants in this industry include AbbVie, Almirall, Boehringer Ingelheim, Ferring Pharmaceuticals, Johnson & Johnson, Norgine Pharmaceuticals, Pfizer, Recordati, Sanofi, and Takeda Pharmaceuticals.
UK Brugada Syndrome Market Analysis
The UK Brugada Syndrome Market was valued at $31.2 Mn in 2023 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $46.3 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increasing awareness and diagnosis, and advancements in genetic testing. The prominent players of the UK Brugada Syndrome Market are AstraZeneca, Hikma, GlaxoSmithKline, Accord, Siemens Healthineers, Abbott, and Thermo Fisher Scientific, among others.
UK Clinical Nutrition for Chronic Kidney Diseases Market Analysis
UK Clinical Nutrition for Chronic Kidney Diseases Market was valued at $40.80 Mn in 2023 and is predicted to grow at a CAGR of 4.03% from 2023 to 2030, to $53.80 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, technological advancements, and the growing geriatric population. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
UK Dental Endodontics Market Analysis
UK Dental Endodontics Market was valued at $45.50 Mn in 2023 and is predicted to grow at a CAGR of 2.3% from 2023 to 2030, to $53.40 Mn by 2030. The key drivers of this industry include rising demand for tooth preservation, an aging population, technological advancements, and increased awareness. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
UK Blood Disorder Therapeutics Market
UK Blood Disorder Therapeutics Market valued at $348 Mn in 2022, projected to reach $535 Mn by 2030 with a 5.5% CAGR. Increased disease incidence brought on by changes in demographics and lifestyle, government support for healthcare accessibility, and the significant role patient advocacy groups play in spreading awareness and developing cutting-edge therapies are the main drivers of this industry. The UK Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Sanofi, Novo Nordisk, CSL Ltd, Bayer, Celgene, Global Blood Therapeutics, Novartis, Emmaus Life Sciences, Bluebird Bio, etc, among various others.
UK Breast Pump Market Report
The UK Breast Pump Market was valued at $76.4 Mn in 2023 and is predicted to grow at a CAGR of 6.6% from 2023 to 2030, to $119.6 Mn by 2030. The key drivers of the market include the rising female workforce, enhanced features, and consumer awareness. The prominent players in the UK Breast Pump Market are Elvie, Ardo, Tommee Tippee, Koninklijke Philips, Canpol Babies, and Chicco, among others.
UK Cancer Induced Bone Diseases Therapeutics Market
UK Cancer Induced Bone Disease Therapeutics Market valued at $34 Mn in 2022, projected to reach $46 Mn by 2030 with a 3.8% CAGR. The key drivers of this industry include the rising incidence of cancers, a favorable regulatory environment, and technological advancements. The industry is primarily dominated by players such as Advaxis, Takeda, Gradalis, Johnson & Johnson, Hikma, Cellectar, and Amgen among others.
UK Digital Biomarkers Market Analysis
UK Digital Biomarkers Market was valued at $75.40 Mn in 2023 and is predicted to grow at a CAGR of 20.3% from 2023 to 2030, to $274.94 Mn by 2030. The key drivers of this industry include the high prevalence of chronic diseases, focus on preventative healthcare, government initiatives, and growing interest in personalized medicine. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
UK Cardiac Resynchronization Therapy Market
UK Cardiac Resynchronization Therapy Market valued at $125 Mn in 2022, projected to reach $158 Mn by 2030 with a 3% CAGR. The worldwide increase in heart failure instances, propelled by aging demographics and cardiovascular diseases linked to lifestyle, stands as a pivotal factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, key players in this market encompass Abbott, Boston Scientific, Biotronik, Medtronic, St. Jude Medical, Sorin Group, LivaNova, MicroPort Aps, Osypka Med and Terumo Corporation.
UK Congestive Heart Failure Therapeutics Market Analysis
The UK Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $268 Mn in 2022 to $361 Mn by 2030, with a CAGR of 3.8% during the forecast period of 2022-2030. The key drivers include the escalating prevalence of risk factors, continuous innovations in CHF therapies, and an increased government healthcare expenditure, fostering improved access, all collectively propelling market growth. The UK Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including AstraZeneca, Novartis, Boehringer Ingelheim, Amgen, Bristol-Myers Squibb, Johnson and Johnson, Eli Lilly, Hikma Pharmaceuticals, Wockhardt, Medivet Pharmaceuticals, etc., among various others.
UK Exosome Research Market Analysis
The UK Exosome Research Market was valued at $4.4 Mn in 2023 and is projected to grow at a CAGR of 14% from 2023 to 2023, to $11 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as AMS Biotechnology, Evox Therapeutics, Thermo Fisher Scientific among others.
UK Physiotherapy Equipment Market Analysis
The UK Physiotherapy Equipment Market was valued at $543.40 Mn in 2023 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $774.87 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are Invacare, Dynatronics, Enraf-Nonius BV, and Wessex Lift Co Ltd among others.
UK Patient Adherence Programs Market Analysis
The UK Patient Adherence Programs Market was valued at $336.9 Mn in 2023 and is predicted to grow at a CAGR of 16% from 2023 to 2030, to $952 Mn by 2030. The key drivers of the market include increasing non-adherence, rising awareness, and technological innovations. The prominent players of the UK Patient Adherence Programs Market are AstraZeneca, Johnson & Johnson, Bayer, GSK, Merck, and Novartis, among others.
UK Dental Consumables Market Analysis
The UK Dental Consumables Market was valued at $878.8 Mn in 2023 and is projected to grow at a CAGR of 6.0% from 2023 to 2023, to $1321.4 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as Ultradent Products, Henry Schein, Dentsply Sirona, 3M Oral Care, Carestream Dental among others.
UK Cardiac Arrhythmia Therapeutics Market Analysis
UK Cardiac Arrhythmia Therapeutics Market valued at $187 Mn in 2022, projected to reach $252 Mn by 2030 with a 3.8% CAGR. The key drivers of this industry include the rising burden of cardiac arrhythmias, increasing focus on preventive care, and technological advancements. The industry is primarily dominated by players such as Abbott, Teva, Bayer, AstraZeneca, Boston Scientific, Sanofi, and Pfizer among others.
UK LASIK Surgery Market Analysis
UK LASIK Surgery Market was valued at $91.78 Mn in 2023 and is predicted to grow at a CAGR of 3.21% from 2023 to 2030, to $114.50 Mn by 2030. The key drivers of this industry include rising demand for vision corrections, increasing disposable income, and technological advancements. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Nidek Co. Ltd., and Carl ZEISS AG, among others.
UK Biosensors Market Analysis
The UK Biosensors Market was valued at $751.4 Mn in 2023 and is predicted to grow at a CAGR of 6% from 2023 to 2030, to $1129.8 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, emphasis on preventative care, and technological advancements. The prominent players of the UK Biosensors Market are Lifesensors, Siemens Healthcare, B. Braun Melsungen AG, Meridian Bioscience, and Biosensors International, among others.
UK Hemodialysis Vascular Grafts Market Analysis
UK Hemodialysis Vascular Grafts Market was valued at $5.45 Bn in 2023 and is predicted to grow at a CAGR of 3.1% from 2023 to 2030, to $6.74 Bn by 2030. The key drivers of this industry include the rising prevalence of ESRD, the aging population, government investment in healthcare, and technological advancements. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.
UK Breastfeeding Accessories Market Analysis
UK Breastfeeding Accessories Market was valued at $65.26 Mn in 2023 and is predicted to grow at a CAGR of 4.80% from 2023 to 2030, to $90.61 Mn by 2030. The key drivers of this industry include a high breastfeeding rate, government support and initiatives, and growth of e-commerce. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
UK Hospital Market Analysis
The UK Hospital Market was valued at $142.99 Bn in 2023 and is predicted to grow at a CAGR of 5.6% from 2023 to 2030, to $209.39 Bn by 2030. The key drivers of this industry are rise in geriatric population, technological advancements, and government initiatives. The key players in the industry are Royal Brompton & Harefield Hospitals Specialist Care, London Bridge Hospital, Nuffield Health Cambridge Hospital, and Bupa Cromwell Hospital among others.
